Masimo Corporation (NASDAQ:MASI) Given Consensus Rating of “Hold” by Brokerages

Shares of Masimo Corporation (NASDAQ:MASI) have received a consensus recommendation of “Hold” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $181.1667.

Several equities analysts have recently issued reports on MASI shares. Wells Fargo & Company cut Masimo from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $190.00 to $180.00 in a report on Wednesday, February 18th. Bank of America initiated coverage on Masimo in a report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective on the stock. Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Stifel Nicolaus set a $180.00 price target on Masimo in a research report on Tuesday, February 17th.

Institutional Trading of Masimo

Large investors have recently bought and sold shares of the business. Naya Capital Management UK Ltd. acquired a new position in Masimo during the fourth quarter worth $202,984,000. AQR Capital Management LLC increased its stake in Masimo by 3,416.5% during the 4th quarter. AQR Capital Management LLC now owns 1,091,326 shares of the medical equipment provider’s stock worth $141,938,000 after buying an additional 1,060,292 shares during the period. Viking Global Investors LP acquired a new stake in Masimo during the 2nd quarter worth approximately $129,096,000. Squarepoint Ops LLC boosted its position in Masimo by 738.8% in the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock valued at $91,619,000 after buying an additional 546,905 shares during the period. Finally, Westfield Capital Management Co. LP grew its stake in shares of Masimo by 75.9% in the second quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock worth $198,702,000 after acquiring an additional 509,724 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Down 0.0%

NASDAQ:MASI opened at $175.42 on Monday. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.92. The company’s fifty day moving average price is $147.24 and its 200-day moving average price is $144.84. Masimo has a 1-year low of $125.94 and a 1-year high of $176.81. The firm has a market capitalization of $9.42 billion, a P/E ratio of -16.64, a PEG ratio of 1.78 and a beta of 1.21.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.